Skip to Content
Merck
CN
  • Making rational treatment decisions in rheumatoid arthritis when methotrexate fails.

Making rational treatment decisions in rheumatoid arthritis when methotrexate fails.

The New England journal of medicine (2013-06-13)
Joan M Bathon, Donald J McMahon
PMID23755970
MATERIALS
Product Number
Brand
Product Description
H0915
Sigma-Aldrich
Hydroxychloroquine sulfate, ≥98% (HPLC), powder
A6770
Sigma-Aldrich
Methotrexate hydrate, ≥98% (HPLC), powder
M8407
Sigma-Aldrich
Methotrexate hydrate, powder, BioReagent, suitable for cell culture, ≥98% (HPLC)
M9929
Sigma-Aldrich
Methotrexate, meets USP testing specifications
06563
Sigma-Aldrich
Methotrexate hydrate, ≥99.0% (sum of enantiomers, HPLC)
M-136
Supelco
Methotrexate solution, 1.0 mg/mL in methanol with 0.1N NaOH, ampule of 1 mL, certified reference material, Cerilliant®
Y0000602
Methotrexate for peak identification, European Pharmacopoeia (EP) Reference Standard
S0883
Sigma-Aldrich
Sulfasalazine, 97.0-101.5%
M1000000
Methotrexate, European Pharmacopoeia (EP) Reference Standard